Improving Cancer Outcomes for Underserved Populations in SE North Carolina

改善北卡罗来纳州东南部服务不足人群的癌症治疗结果

• 批准号: 8305652
• 负责人: PATRICK David MAGUIRE
• 金额: $ 31.83万
• 依托单位: NEW HANOVER REGIONAL MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-09 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8305652
• 关键词: Address; African American; Clinical Research; Clinical Trials; Communities; Community Clinical Oncology Program; Funding; Goals; Grant; Health; Hispanics; Institution; Malignant Neoplasms; Minority; Minority-Based Community Clinical Oncology Program; North Carolina; Oncologist; Outcome; Patients; Population; Research Infrastructure; Research Personnel; Underrepresented Minority; Underserved Population; base; cancer care; cancer prevention; improved; patient population; programs; symptom management

DESCRIPTION (provided by applicant): The primary objective of the project is to increase accrual of African American and other underserved patient populations in Southeastern North Carolina (SENC) onto NCI-sponsored clinical trials. The ultimate goal at the completion of the five-year grant funding period will be for NHRMC to apply to become a minority-based Community Clinical Oncology Program (MB-CCOP) or standard CCOP by achieving the required annual patient accrual rates for these programs. Based upon the current patient population, NHRMC would not be able to eligible to apply for MB-CCOP status. African Americans comprise approximately 25% of the total patient population in SENC as well as at ZCC specifically, far short of the 40% minority population required to be eligible for MB-CCOP application. However, inclusion of Hispanic and poor White patient's results in a total of approximately 38-40% underserved population. In either case, whether MB-CCOP or standard CCOP status is sought, the addition of cancer prevention and symptom management studies as well as three planned investigator-initiated studies described herein will greatly enhance the likelihood that this goal is achieved. Secondary program objectives will be to: 1) Sustain and grow a robust clinical trials infrastructure; 2) Increase the number of oncologists both in the community and in the academic partner institutions that are actively involved in clinical research that specifically addresses underserved populations; 3) Continue to break down barriers to cancer care for the underserved via an increasingly independent patient navigation program.

描述（由申请人提供）： 该项目的主要目的是将北卡罗来纳州东南部（SENC）的非裔美国人和其他服务不足的患者人口增加到NCI赞助的临床试验。完成五年赠款期间完成的最终目标是NHRMC申请成为少数族裔的社区临床肿瘤学计划（MB-CCOP）或标准CCOP，通过实现这些计划的年度患者应计费率。基于当前的患者人群，NHRMC将无法申请MB-CCOP状态。非洲裔美国人约占SENC总数和ZCC总人口总数的25％，远远低于符合MB-CCOP申请所需的40％少数族裔人口。然而，包括西班牙裔和贫穷的白人患者的纳入总数约为38-40％的人群。无论哪种情况，无论是寻求MB-CCOP还是标准CCOP状态，都可以增加预防癌症和症状管理研究，以及本文所述的三项计划的研究人员发起的研究将极大地增加实现此目标的可能性。次要计划目标将是：1）维持和发展强大的临床试验基础设施； 2）增加社区和学术合作伙伴机构的肿瘤学家数量，这些机构积极参与了专门针对服务不足人群的临床研究； 3）继续通过越来越独立的患者导航计划打破服务不足的癌症护理障碍。